GlassScriptPhysician profile
Michelle Haimowitz
NPI 1275775496
$666.08
in general payments reported to CMS, 2019-2025
10 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Pediatrics, Critical Care provider received nationally (typical 2025 total: $80.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $73.19 · 2023: $142 · 2024: $292 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirum Pharmaceuticals, INC. | $216.32 | 2024-2025 | Livmarli |
| Regeneron Healthcare Solutions, INC. | $153.83 | 2022-2024 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $77.07 | 2024-2025 | Eohilia, Gattex |
| Kyowa Kirin, INC. | $64.00 | 2025 | |
| Genzyme Corporation | $44.06 | 2022-2024 | |
| Ipsen Biopharmaceuticals, INC | $30.68 | 2025 | Iqirvo |
| Vertex Pharmaceuticals Incorporated | $23.65 | 2023 | Trikafta |
| Qol Medical, LLC | $21.86 | 2023 | Sucraid |
| Nestle Healthcare Nutrition INC. | $17.36 | 2022 | |
| Celltrion USA INC. | $17.25 | 2025 | Vegzelma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Haimowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.